⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for vulvar carcinoma

Every month we try and update this database with for vulvar carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsNCT03517488
Melanoma
Breast Carcinom...
Hepatocellular ...
Urothelial Carc...
Squamous Cell C...
Renal Cell Carc...
Colorectal Carc...
Non-small Cell ...
Gastric or Gast...
Endometrial Car...
Mesothelioma
Neuroendocrine ...
Cervical Cancer
Small Cell Lung...
Squamous Cell C...
Castration-Resi...
Nasopharyngeal ...
Cholangiocarcin...
Basal Cell Carc...
Ovarian Carcino...
Fallopian Tube ...
Thymoma
Thymic Carcinom...
Squamous Cell C...
Vulvar Carcinom...
Solid Tumors Wi...
Malignant Adnex...
Non-squamous Ce...
XmAb20717
18 Years - Xencor, Inc.
Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation TherapyNCT04713618
Anal Carcinoma
Cervical Carcin...
Endometrial Car...
Malignant Pelvi...
Rectal Carcinom...
Vaginal Carcino...
Vulvar Carcinom...
Pelvic Examinat...
Survey
18 Years - Ohio State University Comprehensive Cancer Center
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer SurvivorsNCT03372720
Cervical Carcin...
Dyspareunia
Endometrial Car...
Ovarian Carcino...
Vaginal Carcino...
Vaginal Dryness
Vulvar Carcinom...
Laser Therapy
Questionnaire A...
Sham Interventi...
- Ohio State University Comprehensive Cancer Center
Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNCT02834013
Acinar Cell Car...
Adenoid Cystic ...
Adrenal Cortica...
Adrenal Gland P...
Anal Canal Neur...
Anal Canal Undi...
Angiosarcoma
Apocrine Neopla...
Appendix Mucino...
Bartholin Gland...
Basal Cell Carc...
Bladder Adenoca...
Breast Metaplas...
Cervical Adenoc...
Cholangiocarcin...
Chordoma
Colorectal Squa...
Desmoid Fibroma...
Endometrial Tra...
Endometrioid Ad...
Esophageal Neur...
Esophageal Undi...
Extrahepatic Bi...
Extramammary Pa...
Fallopian Tube ...
Fallopian Tube ...
Fibromyxoid Tum...
Gallbladder Car...
Gastric Neuroen...
Gastric Squamou...
Gastric Undiffe...
Gastrointestina...
Gestational Tro...
Giant Cell Carc...
Human Papilloma...
Intestinal Neur...
Intrahepatic Ch...
Lung Neuroendoc...
Lung Sarcomatoi...
Major Salivary ...
Malignant Odont...
Malignant Perip...
Malignant Solid...
Malignant Testi...
Metastatic Mali...
Metastatic Pitu...
Minimally Invas...
Mixed Mesoderma...
Mucinous Adenoc...
Mucinous Cystad...
Nasal Cavity Ad...
Nasal Cavity Ca...
Nasopharyngeal ...
Nasopharyngeal ...
Nasopharyngeal ...
Oral Cavity Car...
Oropharyngeal U...
Ovarian Adenoca...
Ovarian Germ Ce...
Ovarian Mucinou...
Ovarian Squamou...
Ovarian Transit...
Pancreatic Acin...
Pancreatic Neur...
Paraganglioma
Paranasal Sinus...
Paranasal Sinus...
Parathyroid Gla...
PEComa
Penile Squamous...
Peritoneal Meso...
Placental Chori...
Primary Periton...
Pseudomyxoma Pe...
Rare Disorder
Scrotal Squamou...
Seminal Vesicle...
Seminoma
Serous Cystaden...
Small Intestina...
Small Intestina...
Spindle Cell Ne...
Teratoma With S...
Testicular Non-...
Thyroid Gland C...
Tracheal Carcin...
Transitional Ce...
Ureter Adenocar...
Ureter Squamous...
Urethral Adenoc...
Urethral Squamo...
Vaginal Adenoca...
Vaginal Squamou...
Vulvar Carcinom...
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their CaregiversNCT02412124
Cervical Carcin...
Ovarian Carcino...
Uterine Corpus ...
Vaginal Carcino...
Vulvar Carcinom...
Supportive Care
Quality-of-Life...
Questionnaire A...
19 Years - City of Hope Medical Center
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)NCT02628067
Advanced Cancer
Anal Carcinoma
Anal Cancer
Biliary Cancer
Cholangiocarcin...
Bile Duct Cance...
Neuroendocrine ...
Carcinoid Tumor
Endometrial Car...
Endometrial Can...
Cervical Carcin...
Cervical Cancer
Vulvar Carcinom...
Vulvar Cancer
Small Cell Lung...
Small Cell Lung...
Mesothelioma
Thyroid Carcino...
Thyroid Cancer
Salivary Gland ...
Salivary Gland ...
Salivary Cancer
Parotid Gland C...
Advanced Solid ...
Colorectal Carc...
pembrolizumab
pembrolizumab
18 Years - Merck Sharp & Dohme LLC
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)NCT02628067
Advanced Cancer
Anal Carcinoma
Anal Cancer
Biliary Cancer
Cholangiocarcin...
Bile Duct Cance...
Neuroendocrine ...
Carcinoid Tumor
Endometrial Car...
Endometrial Can...
Cervical Carcin...
Cervical Cancer
Vulvar Carcinom...
Vulvar Cancer
Small Cell Lung...
Small Cell Lung...
Mesothelioma
Thyroid Carcino...
Thyroid Cancer
Salivary Gland ...
Salivary Gland ...
Salivary Cancer
Parotid Gland C...
Advanced Solid ...
Colorectal Carc...
pembrolizumab
pembrolizumab
18 Years - Merck Sharp & Dohme LLC
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic MalignanciesNCT02578888
Cervical Carcin...
Ovarian Carcino...
Primary Periton...
Recurrent Cervi...
Recurrent Ovari...
Recurrent Uteri...
Recurrent Vulva...
Uterine Corpus ...
Vulvar Carcinom...
Peritoneal Neop...
Palliative Ther...
Palliative Ther...
- Albert Einstein College of Medicine
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerNCT03180294
Breast Carcinom...
Cervical Carcin...
Ovarian Carcino...
Postmenopausal
Uterine Corpus ...
Vaginal Carcino...
Vulvar Carcinom...
Bupropion 150 m...
Placebo
18 Years - NRG Oncology
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)NCT02628067
Advanced Cancer
Anal Carcinoma
Anal Cancer
Biliary Cancer
Cholangiocarcin...
Bile Duct Cance...
Neuroendocrine ...
Carcinoid Tumor
Endometrial Car...
Endometrial Can...
Cervical Carcin...
Cervical Cancer
Vulvar Carcinom...
Vulvar Cancer
Small Cell Lung...
Small Cell Lung...
Mesothelioma
Thyroid Carcino...
Thyroid Cancer
Salivary Gland ...
Salivary Gland ...
Salivary Cancer
Parotid Gland C...
Advanced Solid ...
Colorectal Carc...
pembrolizumab
pembrolizumab
18 Years - Merck Sharp & Dohme LLC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: